Bayer 20324 ON-TRK
ON-TRK: PrOspective Non-interventional study in patients with locally advanced or metastatic TRK fusion cancer treated with larotrectinib
A phase 1/2, pharmacokinetic multi-tumor study of subcutaneous formulation of ipilimumab monotherapy and in combination with subcutaneous nivolumab
©2019 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.